Andris H Ellims
Overview
Explore the profile of Andris H Ellims including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
912
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernando H, Nehme Z, Peter K, Bernard S, Stephenson M, Bray J, et al.
Int J Cardiol Heart Vasc
. 2021 Nov;
37:100899.
PMID: 34815999
Background: We sought to determine if an association exists between prehospital chest pain severity and markers of myocardial injury. Methods And Results: Patients with confirmed ST elevation myocardial infarction (STEMI)...
2.
Nguyen M, Su Y, Vizi D, Fang L, Ellims A, Zhao W, et al.
Sci Rep
. 2018 May;
8(1):8213.
PMID: 29844319
Galectin-3 is a biomarker of heart disease. However, it remains unknown whether increase in galectin-3 levels is dependent on aetiology or disease-associated conditions and whether diseased heart releases galectin-3 into...
3.
Costello B, Stub D, Hare J, Ellims A, Wang X, Smith K, et al.
Heart Lung Circ
. 2018 Mar;
28(3):397-405.
PMID: 29526416
Background: Late gadolinium enhancement (LGE) with cardiac magnetic resonance (CMR) is commonly assumed to represent myocardial fibrosis; however, comparative human histological data are limited, and there is no consensus on...
4.
Fang L, Ellims A, Beale A, Taylor A, Murphy A, Dart A
Am J Transl Res
. 2017 Dec;
9(11):5063-5073.
PMID: 29218105
Background: Regional or diffuse fibrosis is an early feature of hypertrophic cardiomyopathy (HCM) and is related to poor prognosis. Previous studies have documented low-grade inflammation in HCM. The aim of...
5.
Ellims A
Aust Fam Physician
. 2017 Aug;
46(8):553-557.
PMID: 28787553
Background: Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease, which generally manifests during adolescence. Adolescents may be diagnosed incidentally, following the investigation of symptoms, or during family screening....
6.
SASHA versus ShMOLLI: a comparison of T1 mapping methods in health and dilated cardiomyopathy at 3 T
Costello B, Springer F, Hare J, La Gerche A, Iles L, Ellims A, et al.
Int J Cardiovasc Imaging
. 2017 Jun;
33(10):1551-1560.
PMID: 28589482
Cardiac Magnetic Resonance derived T1 mapping parameters are a non-invasive method of estimating diffuse myocardial fibrosis. This study aims to to determine the native T1 time, post contrast T1 time...
7.
Alexis J, Costello B, Iles L, Ellims A, Hare J, Taylor A
J Echocardiogr
. 2016 Nov;
15(1):27-36.
PMID: 27817093
Background: We evaluated the ability of transthoracic echocardiography (TTE) to correctly identify abnormal left ventricular (LV) size, function, and mass when compared to cardiac magnetic resonance (CMR). Whilst numerous studies...
8.
McLellan A, Ellims A, Prabhu S, Voskoboinik A, Iles L, Hare J, et al.
J Cardiovasc Electrophysiol
. 2016 Feb;
27(5):571-80.
PMID: 26840595
Introduction: Non-sustained ventricular tachycardia (NSVT) is a risk factor for sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM). We aimed to assess whether diffuse ventricular fibrosis on cardiac...
9.
Stub D, Smith K, Bernard S, Nehme Z, Stephenson M, Bray J, et al.
Circulation
. 2016 Jan;
133(3):e29.
PMID: 26783283
No abstract available.
10.
Nehme Z, Stub D, Bernard S, Stephenson M, Bray J, Cameron P, et al.
Heart
. 2016 Jan;
102(6):444-51.
PMID: 26740484
Objective: Supplemental oxygen therapy may increase myocardial injury following ST-elevation myocardial infarction (STEMI). In this study, we aimed to evaluate the effect of the dose and duration of oxygen exposure...